VECT
Price:
$16.87
Market Cap:
$1.06B
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvH...[Read more]
Industry
Biotechnology
IPO Date
2021-04-08
Stock Exchange
NASDAQ
Ticker
VECT
According to VectivBio Holding AG’s latest financial reports and current stock price. The company's current ROE is -56.92%. This represents a change of 78.08% compared to the average of -31.96% of the last 4 quarters.
The mean historical ROE of VectivBio Holding AG over the last ten years is -112.13%. The current -56.92% ROE has changed -49.24% with respect to the historical average. Over the past ten years (40 quarters), VECT's ROE was at its highest in in the June 2018 quarter at 0%. The ROE was at its lowest in in the June 2019 quarter at -508.12%.
Average
-112.13%
Median
-75.01%
Minimum
-254.06%
Maximum
0%
Discovering the peaks and valleys of VectivBio Holding AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -254.06%
| Year | ROE | Change |
|---|---|---|
| 2022 | -43.93% | -41.43% |
| 2021 | -75.01% | -60.03% |
| 2020 | -187.66% | -26.14% |
| 2019 | -254.06% | -Infinity% |
The current ROE of VectivBio Holding AG (VECT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-102.20%
5-year avg
-112.13%
10-year avg
-112.13%
VectivBio Holding AG’s ROE is greater than Gracell Biotechnologies Inc. (-37.93%), greater than Ethzilla Corp. (-240.64%), greater than Verve Therapeutics, Inc. (-16.77%), less than EQRx, Inc. (14.15%), greater than Crescent Biopharma, Inc. (-100.86%), greater than Albireo Pharma, Inc. (-84.83%), greater than Poseida Therapeutics, Inc. (-84.75%), less than CTI BioPharma Corp. (1.32%), greater than Chimerix, Inc. (-56.17%),
| Company | ROE | Market cap |
|---|---|---|
| -37.93% | $197.97M | |
| -240.64% | $56.39M | |
| -16.77% | $994.04M | |
| 14.15% | $1.14B | |
| -100.86% | $487.75M | |
| -84.83% | $915.89M | |
| -84.75% | $925.93M | |
| 1.32% | $1.20B | |
| -56.17% | $801.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VectivBio Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VectivBio Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is VectivBio Holding AG's ROE?
How is the ROE calculated for VectivBio Holding AG (VECT)?
What is the highest ROE for VectivBio Holding AG (VECT)?
What is the 3-year average ROE for VectivBio Holding AG (VECT)?
What is the 5-year average ROE for VectivBio Holding AG (VECT)?
How does the current ROE for VectivBio Holding AG (VECT) compare to its historical average?